Chugai obtains regulatory approval for Evrysdi for the treatment of Spinal Muscular Atrophy

Dear Investor,Please find attached a press release by Chugai:https://www.roche.com/210623_IR_Chugai_eEvrysdi_approval.pdfDo not hesitate to contact us for any further questions.With best regards,
Source: Roche Investor Update - Category: Pharmaceuticals Source Type: news